3TR: young and senior asthma and COPD patients involved in biomarker research
3TR is a high-end research project that aims at improving treatment available for asthma and COPD. Funded by the Innovative Medicine Initiative (IMI),...
EFA response to the review of the EU Regulation on Fluorinated Greenhouse Gases
In September EFA participated in the Inception Impact Assessment consultation launched by the European Commission Directorate General for Climate Action...
The psychological burden of atopic eczema will be discussed at the EADV Congress
The 2020 EADV Congress will take place from the 29-31 of October, as a global virtual event. Do not miss EFA’s session on the socio-psychological burden...
We showed how much we #CareforAtopicEczema
We are stronger together! On 14th September we celebrated World Atopic Eczema Day. The day connected patients, caregivers, healthcare professionals, and...
PRESS RELEASE: 3rd World Atopic Eczema Day
How do YOU care for atopic eczema?
World Atopic Eczema Day challenges patients, healthcare professionals and policy makers around the world to unite for...
Why the EU should create a food safety culture to protect people with allergies
There are around 17 million people living with food allergies in Europe. Each one needs to constantly check the ingredients in the food they purchase and...
Adapting to Climate Change: Europe cannot ignore impacts on health
Climate change is an increasing risk to people’s health, yet health is not a widely discussed topic alongside the climate. Those with allergy and respiratory...
The World Atopic Eczema Day 2020 toolkit is out! Join the movement on September 14th
On September 14th, the European Federation of Allergies and Airways Diseases Patients’ Associations (EFA), together with Global Skin and the atopic eczema...
EFA contributes to the WHO Europe’s Programme of Work
As the European voice of the 200 million of people living with asthma, allergy and COPD, EFA has participated in the open consultation organised by the...
Future EU Health and Research budgets cuts contrary to patients needs
After days of intensive negotiations, the agreement reached on 21 July in the European Council on the budget for the Covid-19 recovery and the next Multiannual...
September 14th is World Atopic Eczema Day - Join us!
Each September 14th, the atopic eczema patient community marks World Atopic Eczema Day. This year we will focus on how atopic eczema shapes family life.
How...
Save the Date: EFA Allergy and Respiratory Patient Digital Conference
EFA is glad to announce its first Allergy and Respiratory Patient Conference, a semi-virtual event that will take place on October 23 – 24 2020. Focusing...
EFA provides patient information in COVID-19 resource hub
Coronavirus or COVID-19 is a communicable respiratory disease. It affects those most, who are already vulnerable, especially, people living with chronic...
CURE asthma project makes good progress
On May 14th, the second review meeting of the CURE asthma project took place. Due to COVID-19 restrictions, the update had to happen virtually.
Being...
3TR: Involving asthma and COPD patients in research
Treatments for autoimmune, inflammatory and allergic diseases are widely available. Yet the response to therapy and also disease progression is unpredictable...
New goals, new name, new website - Exciting times for Czech Initiatve for Asthma
EFA Member, Czech Initiative for Asthma is experiencing exciting times. Not only has the organisation changed its name into Czech Civic Association Against...
"It's in the air" - Reducing weather and climate risks
EFA Member Finnish Organisation for Respiratory Health has published an English version of its programme “It’s in the air”. The programme aims at...
Warning Signals - Swedish Heart and Lung Association publishes video campaign
“Listen to your body. Take warning signals seriously”, this is the message that EFA Member Swedish Heart and Lung Association wants to carry through...
Atopic Eczema Working Group: COVID-19 Special
On June 8, EFA hosted a special Atopic Eczema Working Group call, specifically focussing on coronavirus and atopic eczema. With the support of organizers...
Relaxation of food labelling measures puts allergic patients at risk
In early May, EFA Member French Allergy Prevention Association (AFPRAL) alerted to a potential relaxation of food labeling measures by the DGCCRF (Directorate...